HUT60490A - Process for producing quinoline derivatives - Google Patents

Process for producing quinoline derivatives Download PDF

Info

Publication number
HUT60490A
HUT60490A HU92933A HUP9200933A HUT60490A HU T60490 A HUT60490 A HU T60490A HU 92933 A HU92933 A HU 92933A HU P9200933 A HUP9200933 A HU P9200933A HU T60490 A HUT60490 A HU T60490A
Authority
HU
Hungary
Prior art keywords
ethyl
alkyl
formula
methyl
hydrogen
Prior art date
Application number
HU92933A
Other languages
English (en)
Hungarian (hu)
Inventor
Arnold Harry Ratcliffe
Emyr Glyn Williams
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of HU9200933D0 publication Critical patent/HU9200933D0/hu
Publication of HUT60490A publication Critical patent/HUT60490A/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU92933A 1990-08-09 1991-07-30 Process for producing quinoline derivatives HUT60490A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Publications (2)

Publication Number Publication Date
HU9200933D0 HU9200933D0 (en) 1992-05-28
HUT60490A true HUT60490A (en) 1992-09-28

Family

ID=10680406

Family Applications (1)

Application Number Title Priority Date Filing Date
HU92933A HUT60490A (en) 1990-08-09 1991-07-30 Process for producing quinoline derivatives

Country Status (15)

Country Link
EP (1) EP0495948A1 (cs)
JP (1) JPH05501728A (cs)
KR (1) KR920702357A (cs)
CN (1) CN1058965A (cs)
AU (1) AU8309091A (cs)
CA (1) CA2047249A1 (cs)
CS (1) CS88692A3 (cs)
FI (1) FI921319A0 (cs)
GB (2) GB9017479D0 (cs)
HU (1) HUT60490A (cs)
IE (1) IE912406A1 (cs)
IL (1) IL98833A0 (cs)
PT (1) PT98607A (cs)
WO (1) WO1992002508A1 (cs)
ZA (1) ZA915567B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
RS60093B1 (sr) 2013-09-16 2020-05-29 Astrazeneca Ab Terapeutske polimerne nanočestice i postupci njihove pripreme i primene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
EP0412848B1 (en) * 1989-08-11 1995-01-18 Zeneca Limited Quinoline derivatives, process for their preparation and their use as medicaments

Also Published As

Publication number Publication date
CN1058965A (zh) 1992-02-26
AU8309091A (en) 1992-03-02
PT98607A (pt) 1992-06-30
IL98833A0 (en) 1992-07-15
JPH05501728A (ja) 1993-04-02
CS88692A3 (en) 1992-10-14
FI921319L (fi) 1992-03-26
GB9017479D0 (en) 1990-09-26
EP0495948A1 (en) 1992-07-29
FI921319A7 (fi) 1992-03-26
HU9200933D0 (en) 1992-05-28
GB9115250D0 (en) 1991-08-28
WO1992002508A1 (en) 1992-02-20
IE912406A1 (en) 1992-02-12
CA2047249A1 (en) 1992-02-10
KR920702357A (ko) 1992-09-03
FI921319A0 (fi) 1992-03-26
ZA915567B (en) 1992-07-29

Similar Documents

Publication Publication Date Title
AU646473B2 (en) Process for the manufacture of biphenylcarbonitriles
AP161A (en) Novel Quinoline derivatives.
US5126344A (en) Diazine derivatives and pharmaceutical use
US5171748A (en) Benz[4,5]imidazole-containing angiotensin antagonists
US5217976A (en) 1,6-naphthyridone derivatives having angiotensin ii antagonist activity
US5420292A (en) Biphenyl-tetrazole intermediate compounds
JPH04244080A (ja) ビフエニルカルボニトリルの製法
HUT60490A (en) Process for producing quinoline derivatives
PT100024A (pt) Novos compostos de boro e processo para a sua preparacao
CA2065078A1 (en) Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
CZ299598A3 (cs) Benzopyranové deriváty, způsob jejich výroby a farmaceutický prostředek
JPH05239053A (ja) キノリン誘導体ならびにその製造方法および治療への応用
JPH04225959A (ja) 複素環式化合物
SU730306A3 (ru) Способ получени производных пиразоло (1,5-с) хиназолина или солей
FR2684672A1 (fr) Derives de pyrimidine, utiles pour le traitement d'etats tels que l'hypertension et l'insuffisance cardiaque, et procede pour leur preparation.
CA2066005A1 (en) Nitrogen derivatives
US5198434A (en) Angiotensin ii antagonizing fused pyridinyloxy containing derivatives
US5334718A (en) Chemical process and intermediates used therein
NO843292L (no) Fremgangsmaate for fremstilling av nye kinolon-derivater
US5371227A (en) Quinoline derivatives, process for their preparation, and their therapeutic applications
NO151464B (no) Fremgangsmaate ved fremstilling av 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidin-4-on-derivater
JPH0227345B2 (cs)
JPH0633255B2 (ja) テトラヒドロキノリン誘導体

Legal Events

Date Code Title Description
DFC9 Refusal of application